Buprenorphine

Clinical Guidelines for the Use of Buprenorphine
in the Treatment of Opioid Addiction

Treatment Improvement Protocol (TIP) 40 is the first clinical practice consensus guide produced by leading experts on the use of buprenorphine for the treatment of patients addicted or dependent on heroin or prescription pain medications, such as oxycodone, hydrocodone, or meperidine. The guidelines cover screening, assessment, and diagnosis of opioid dependence and its associated problems; assessment protocols for use in determining when buprenorphine is an appropriate treatment option; referrals to treatment professionals to provide the counseling and participation in self-help programs needed by most patients addicted to heroin or opioid prescription pain medications; detailed clinical protocols for use of buprenorphine in a variety of scenarios; and guidance on co-occurring pain, psychological disorders, or chemical dependency involving more than one substance.

Download a copy of the Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction (pdf, 1.1 MB).

TIP 40 is available by calling 1-800-729-6686. It will also be available in the near future from the National Library of Medicine (NLM), or by calling 1-888-346-3656.

For additional information regarding Buprenorphine, please go to SAMHSA’s National Clearing House for Alcohol and Drug Information (NCADI).

Patient and Family Brochure, Introducing Office-Based
Treatment for Opioid Addiction

Introducing Office-Based Treatment for Opioid Addiction is a new publication designed to provide patients and their families with important information about opioid addiction treatment with buprenorphine outside of the context of the traditional Opioid Treatment Program. The pamphlet provides an overview of buprenorphine and how it can be prescribed to treat addiction to opioids in the office-based setting. The brochure encourages patients to work with their health care provider to learn more about this new treatment.